ALIGN TECHNOLOGY INC (ALGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ALGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALGN | Chairman of the Board | 77 | ["1999 - 2010 Principal, Group Outcome L.L.C. (merchant banking)","2003 - 2007 CEO, Eunoe, Inc. (medical device company)","Venture Partner, Cutlass Capital (venture capital firm)","President and CEO, Nellcor Puritan Bennett, Inc. (respiratory products companies)","Chair at Shockwave Medical, Inc. (2019-2024)","Experience with the growth and maturation of medical device companies"] | ["Nominating and Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age : 77 Director Since : 2004 Roles : Independent Director; Chairman of the Board Committees : Nominating and Governance Committee Election Term: 2026-2027 Experience: 1999 - 2010 Principal, Group Outcome L.L.C. (merchant banking) 2003 - 2007 CEO, Eunoe, Inc. (medical device company) Prior Venture Partner, Cutlass Capital (venture capital firm) President and CEO, Nellcor Puritan Bennett, Inc. (respiratory products companies) Other Board Positions Shockwave Medical, Inc., Chair (2019-2024) Neuropace (2008-2019) Heartware, Inc., Chair (2008-2018) Reva Medical, Inc., Chair (2008-2018) Notable Experience and Key Board Contributions Mr. Larkin brings significant leadership experience at large public companies, a deep knowledge and authority in the medical device and healthcare fields, extensive public and private company board experience, and strong strategic business development and tactical implementation skills. Mr. Larkin has unique experience with the growth and maturation of a medical device company. He grew Nellcor to nearly $1 billion in revenues through the development and introduction of pulse oximetry into worldwide use for patient safety monitoring, setting the standard of care for the respiratory-impaired patient. Mr. Larkin served in the United States Marine Corps, rising to the level of Captain. Education B.S. in Industrial Management from LaSalle University